期刊文献+

抑制信号转导与转录激活因子3对人前列腺癌细胞DU145生长的作用研究

The Effect of Abrogating STAT3 on Human Prostate Cancer Cell Growth
下载PDF
导出
摘要 目的:研究抑制信号转导与转录激活因子3(STAT3)表达对人前列腺癌细胞DU145生长的影响。方法:用慢病毒p FLU-EGFP STAT3 shRNA(shRNA)质粒转染人前列腺癌细胞DU145构建抑制STAT3表达的稳定细胞株作为shRNA组,转染空载体作为空白对照(mock)组,采用荧光定量聚合酶链式反应(q PCR)和免疫印迹(Western blot)方法检测STAT3的mRNA和蛋白的表达水平,用结晶紫染色法检测抑制STAT3表达对细胞生长的影响;用Matrigel细胞侵袭实验检测抑制STAT3表达对DU145细胞迁移侵袭能力的影响。结果:与mock组相比,shRNA组STAT3 mRNA和蛋白表达水平显著下降,约为mock组的15%和20%,shRNA组DU145细胞的生长数目明显减少,仅为空白对照组的41.8%;shRNA组DU145细胞对基底膜的侵袭能力降低,抑制率为mock组52.9%。结论:抑制STAT3表达可降低前列腺癌细胞生长和迁移能力。 Objective: To investigate the effect of STAT3 silencing on growth and invasion of human prostate cancer cells. Methods: Lentiviruses expressing STAT3-specific shRNA were used to infect human prostate cancer DU145 cells to generate a stable cell line as shRNA group,non-specific shRNA as mock group. STAT3 expression was assessed by q PCR at transcriptional level and Western blot at protein level. The effect of STAT3 inhibition on cell growth was determined by crystal violet staining.Matrigel invasion assay was used to evaluate the effect of STAT3 inhibition on cell invasion. Results:Compared to mock group,STAT3 expression were silenced about 15% at transcriptional level and 20%at protein level. Cell growth was significantly delayed in shRNA group,about 41. 8% of mock control.STAT3 silencing significantly impaired cell invasion ability and invaded cells were about 52. 9% of mock group. Conclusions: Inhibiting STAT3 expression hinders growth and invasion of human prostate cancer cells.
出处 《贵阳医学院学报》 CAS 2015年第11期1150-1153,共4页 Journal of Guiyang Medical College
基金 国家自然科学基金项目(No.81560482) 贵州省"2011协同创新中心"支助项目[黔教合协同创新中心(2014)06] 贵州省科技厅重大专项[黔科合计Z字(2012)4010] 贵州省科技厅计划项目[黔科合LG字(2012)009]
关键词 信号转导与转录激活因子3 前列腺癌细胞 细胞生长 细胞侵袭 signal transducer and activator of transcription prostate cancer cells cell growth cell invasion
  • 相关文献

参考文献12

  • 1DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treat- ment and survivorship statistics, 2014[ J]. CA: a cancer journal for clinicians, 2014(4) :252 -271.
  • 2Yu H, Lee H, Herrmann A, el al. Revisiting STAT3 sig- nalling in eancer: new and unexpected biological func- tions[J]. Nat Rev Cancer, 2014 (11) :736 -746.
  • 3Buetiner R, Mora I,B, Jove R. Aetivated STAT signaling in human tumors provides novel molecular targets for therapeu- tic inlervention[J]. Clin Cancer Res, 2002(8):945-954.
  • 4McCann CA, Naidu S, Rath KS, et al. Tm'gling constitutive- ly-aetivated STAT3 in hy[xxic owuian cancer, using a lrwel STNF3 illhibitor[J]. Oncoscience, 2014(1) :216-228.
  • 5Shi I,, Wang S, Zangari M, et al. Over-expression of CKSI B activates both MEK/ERK and JAK/STAT3 signa- ling pathways and prnmoles myelnma cell drug-resistance [J]. Oncntarget, 2010(1):22-33.
  • 6Mnra LB, Buettner R, Scignc J, el al. Constitutive activa- tion of Star3 in human proslale tumors and cell lines: direcl inhibition eft Star3 signaling induces apoptosis of proslate cancer cells [J]. Cancer Rcs, 2002(22):6659 -6666.
  • 7Morcira D, Zhang Q, Hnssain DM, et al. TLR9 signaling du'ongh NF-KB/RELA and STAT3 prnmotes tumor-propa- gating potential of prnstate caneer cells[ J]. Oncotarget, 2015(19) :17302 - 17313.
  • 8Gu L, Dagvadorj A, Lutz J, et al. Transcription facinrStat3 stinmlates metaslatic behavior of human prostate cancer cells in viv'o, whereas Stal5b has a pretirential role in the pronK*tion of prostate cancer cell viability and tumor growth[Jl. Am J Pathol, 2010(4):1959-1972.
  • 9Liu C, Lou W, Armstrong C, el al. Niclosamide suppres- ses cell migration and invasion ill enzalutamide resistant prostate cancer cells via SIat3-AR axis inhibition [ J ]. Proslale, 2015 (13) :1341 - 1353.
  • 10Zhang Q, Hossain DM, Nchat'v S, el al. TLR9mediated siRNA delivery for targeting of normal and malignant hu- man hematopoietic cells in vivo [ J ]. Blood, 2013 ( 8 ) : 1304 - 1315.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部